 role adjuvant chemotherapy cystectomy invasive bladder cancer prospective comparative trial patients invasive pathological stage N+ Mo transitional cell carcinoma bladder squamous glandular differentiation chemotherapy observation radical cystectomy pelvic lymph dissection patients chemotherapy courses intervals cisplatin doxorubicin cyclophosphamide significant delay time progression patients free disease years observation group Median survival time patients chemotherapy group years years observation group addition treatment groups important prognostic factors age gender lymph node status number involved lymph nodes single important variable adjuvant chemotherapy patients invasive transitional cell carcinoma definitive surgical resection